AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 2 |
Visa
V
|
+$283M |
| 3 |
CVS Health
CVS
|
+$195M |
| 4 |
Texas Instruments
TXN
|
+$188M |
| 5 |
Progressive
PGR
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$274M |
| 2 |
Microsoft
MSFT
|
+$263M |
| 3 |
Comcast
CMCSA
|
+$248M |
| 4 |
Amphenol
APH
|
+$238M |
| 5 |
Elevance Health
ELV
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Financials | 14.66% |
| 3 | Healthcare | 14.25% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPIQ
2201
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $1.03M | ﹤0.01% |
62,291
-1,900
| -3% | -$30.3K |
|
2202
Walker & Dunlop
WD
$1.65B
| $1.02M | ﹤0.01% |
40,545
-1,300
| -3% | -$33K |
|
2203
CNA Financial
CNA
$14.5B
| $1.02M | ﹤0.01% |
29,667
-200
| -0.7% | -$6.5K |
|
2204
National Bank Holdings
NBHC
$1.93B
| $1.02M | ﹤0.01% |
43,600
-29,638
| -40% | -$655K |
|
2205
Southside Bancshares
SBSI
$1.02B
| $1.01M | ﹤0.01% |
32,256
+3
| +0% | +$93 |
|
|
NSM
2206
DELISTED
Nationstar Mortgage Holdings
NSM
| $1.01M | ﹤0.01% |
68,000
| – | – |
|
2207
Greenlight Captial
GLRE
$563M
| $1M | ﹤0.01% |
49,145
-1,000
| -2% | -$20.4K |
|
2208
Groupon
GRPN
$980M
| $1M | ﹤0.01% |
9,750
-1,722
| -15% | -$168K |
|
|
PDLI
2209
DELISTED
PDL BioPharma, Inc.
PDLI
| $1M | ﹤0.01% |
299,722
| – | – |
|
2210
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.26B
| $997K | ﹤0.01% |
13,086
| – | – |
|
2211
BJ's Restaurants
BJRI
$1.41B
| $996K | ﹤0.01% |
28,020
| – | – |
|
|
NPKI
2212
NPK International
NPKI
$1.21B
| $996K | ﹤0.01% |
135,344
-1,190
| -0.9% | -$7.87K |
|
2213
Enviri
NVRI
$621M
| $995K | ﹤0.01% |
100,220
-9,100
| -8% | -$86.7K |
|
|
EEP
2214
DELISTED
Enbridge Energy Partners
EEP
| $994K | ﹤0.01% |
39,097
+755
| +2% | +$18.1K |
|
2215
HEICO Corp
HEI
$48.9B
| $993K | ﹤0.01% |
35,017
-8,301
| -19% | -$234K |
|
|
LDL
2216
DELISTED
Lydall, Inc.
LDL
| $992K | ﹤0.01% |
19,400
+2,800
| +17% | +$131K |
|
2217
Mercury Insurance
MCY
$5.94B
| $989K | ﹤0.01% |
18,024
-220
| -1% | -$11.9K |
|
2218
SB Financial Group
SBFG
$160M
| $987K | ﹤0.01% |
82,576
| – | – |
|
2219
National Healthcare
NHC
$3.53B
| $986K | ﹤0.01% |
14,936
-300
| -2% | -$19.5K |
|
2220
Manitowoc
MTW
$516M
| $982K | ﹤0.01% |
51,230
| – | – |
|
|
RPTP
2221
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $982K | ﹤0.01% |
109,460
| – | – |
|
2222
Coca-Cola Consolidated
COKE
$12.3B
| $978K | ﹤0.01% |
66,000
-10,000
| -13% | -$148K |
|
2223
PTC Therapeutics
PTCT
$6.37B
| $976K | ﹤0.01% |
69,650
-6,000
| -8% | -$48.8K |
|
2224
Upbound Group
UPBD
$1.19B
| $972K | ﹤0.01% |
76,919
| – | – |
|
|
OPB
2225
DELISTED
Opus Bank Common Stock
OPB
| $969K | ﹤0.01% |
27,400
| – | – |
|
Similar funds
AllianceBernstein's Q3 2016 Portfolio in Review
As of Q3 2016, AllianceBernstein held 3,058 positions worth $118B, up 2% from $116B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q3 2016 filing shows 95 new, 1,049 increased, 1,331 reduced and 82 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,294,681 shares worth $106M. The largest sale was Pfizer, an estimated $274M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q3 2016 buy was Teva Pharmaceuticals: 2,294,681 shares worth $106M.
- AllianceBernstein added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $567M increase.
- AllianceBernstein's biggest Q3 2016 reduction was Pfizer, cutting an estimated $274M.
- AllianceBernstein fully exited EMC CORPORATION in Q3 2016, selling an estimated $99.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $118B portfolio in Q3 2016.
- AllianceBernstein opened 95 new positions and closed 82 in Q3 2016.
- AllianceBernstein's portfolio value rose 2% quarter-over-quarter to $118B.
Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.